SOLEUS CAPITAL MANAGEMENT, L.P.
Adviser information for SOLEUS CAPITAL MANAGEMENT, L.P. last updated from Form ADV on March 26th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Limited Partnership |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Delaware, United States |
Employees
| Total Number of Employees | 17 |
|---|---|
| Investment Advisory/Research | 9 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 0 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | Yes |
|---|
| Type | Accounts | RAUM |
|---|---|---|
| Discretionary | 8 | $2.0B |
| Non-Discretionary | 0 | $0 |
| Total | 8 | $2.0B |
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 8 | $2.0B |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 25 |
Services
| Advisory Services | Portfolio management for pooled investment vehicles |
|---|---|
| Compensation | % of AUMPerformance-based fees |
| Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
104 FIELD POINT ROAD2ND FLOOR
GREENWICH
CT
United States
Monday - Friday, 9:00 AM - 5:00 PM
Tel: 475-208-3178, Fax: None
Chief Compliance Officer
STEVEN MUSUMECI
CHIEF OPERATING OFFICER
104 FIELD POINT ROAD, 2ND FLOOR
GREENWICH
CT
United States
Tel:
475-208-3111
S*****@****************M
(Full email address available in API data)
Regulatory Contact
MICHAEL COPPOLA
CHIEF FINANCIAL OFFICER
104 FIELD POINT ROAD, 2ND FLOOR
GREENWICH
CT
United States
Tel:
475-208-1821
M******@****************M
(Full email address available in API data)
Industry Affiliates
| SOLEUS CAPITAL, LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
| SOLEUS CREDIT GP I, LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
| SOLEUS PRIVATE EQUITY GP I, LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
| SOLEUS PRIVATE EQUITY GP II, LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
| SOLEUS PRIVATE EQUITY GP III, LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| SOLEUS BB SPV, LLC | Private Equity Fund | $8.5M | $0.0M | 32 |
| SOLEUS CAPITAL MASTER FUND, L.P. | Hedge Fund | $1,562.4M | $5.0M | 471 |
| SOLEUS CAPITAL SPECIAL OPPORTUNITIES FUND, L.P. | Hedge Fund | $7.2M | $1.0M | 42 |
| SOLEUS PRIVATE EQUITY FUND I, L.P. | Private Equity Fund | $25.3M | $3.0M | 59 |
| SOLEUS PRIVATE EQUITY FUND II, L.P. | Private Equity Fund | $180.9M | $3.0M | 125 |
| SOLEUS PRIVATE EQUITY FUND III, L.P. | Private Equity Fund | $195.1M | $3.0M | 108 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| SOLEUS GP LLC | Domestic Entity | – | GENERAL PARTNER | 12/2017 | < 5% |
| MUSUMECI, STEVEN, JOSEPH | Individual | – | CHIEF OPERATING OFFICER; CHIEF COMPLIANCE OFFICER; LIMITED PARTNER | 02/2018 | < 5% |
| LEVY, GUY, BEZALEL | Individual | – | CHIEF INVESTMENT OFFICER; LIMITED PARTNER | 02/2018 | 50-75% |
| LEVY, GUY, BEZALEL | Individual | SOLEUS GP LLC | SOLE OWNER | 12/2017 | > 75% |
| SP SOLEUS HOLDINGS LLC | Domestic Entity | – | LIMITED PARTNER | 07/2018 | 10-25% |
| DAVIS, CHARLES, ARTHUR | Individual | SP SOLEUS HOLDINGS LLC | MEMBER | 09/2018 | 50-75% |
| CANNER, DAVID, ALLEN | Individual | – | LIMITED PARTNER | 04/2022 | 5-10% |
| FRIEDMAN, STEPHEN, NMN | Individual | SP SOLEUS HOLDINGS LLC | MEMBER | 09/2018 | 25-50% |
| COPPOLA, MICHAEL, ANTHONY | Individual | – | CHIEF FINANCIAL OFFICER | 05/2021 | < 5% |
| GUY LEVY 2018 GST TR | Domestic Entity | – | LIMITED PARTNER | 09/2018 | 5-10% |
| LEVY, NAVEH | Individual | – | TRUSTEE OF GUY LEVY 2018 GST TR | 09/2018 | 5-10% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| 10X GENOMICS INC | CL A COM | 14M | 719K | – |
| 4D MOLECULAR THERAPEUTICS IN | COM | 2M | 109K | – |
| AADI BIOSCIENCE INC | COM | 487K | 333K | – |
| ADAPTIVE BIOTECHNOLOGIES COR | COM | 6M | 2M | – |
| ADVERUM BIOTECHNOLOGIES INC | COM NEW | 1M | 147K | – |
| ALECTOR INC | COM | 10M | 2M | – |
| ALNYLAM PHARMACEUTICALS INC | COM | 17M | 72K | – |
| APPLIED THERAPEUTICS INC | COM | 6M | 1M | – |
| ARCELLX INC | COMMON STOCK | 9M | 171K | – |
| AVADEL PHARMACEUTICALS PLC | COM SHS | 7M | 509K | – |
| AVITA MEDICAL INC | COM | 2M | 267K | – |
| AXOGEN INC | COM | 24M | 3M | – |
| BAUSCH HEALTH COS INC | COM | 8M | 1M | – |
| BEIGENE LTD | SPONSORED ADR | 20M | 138K | – |
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 476K | 24K | – |
| BIOATLA INC | COM | 5M | 4M | – |
| BIODESIX INC | COM | 9M | 6M | – |
| C4 THERAPEUTICS INC | COM STK | 19M | 4M | – |
| CALCIMEDICA INC | COM NEW | 3M | 784K | – |
| CASTLE BIOSCIENCES INC | COM | 19M | 854K | – |
| CELCUITY INC | COM | 20M | 1M | – |
| CERVOMED INC | COM | 2M | 127K | – |
| CG ONCOLOGY INC | COM | 13M | 425K | – |
| CVRX INC | COM | 7M | 587K | – |
| DYNE THERAPEUTICS INC | COM | 7M | 201K | – |
| EDAP TMS S A | SPONSORED ADR | 40M | 7M | – |
| ENANTA PHARMACEUTICALS INC | COM | 10M | 800K | – |
| ENGENE HOLDINGS INC | COM | 8M | 800K | – |
| ENLIVEN THERAPEUTICS INC | COM | 18M | 769K | – |
| ERASCA INC | COM | 5M | 2M | – |
| ESSA PHARMA INC | COM NEW | 22M | 4M | – |
| ESTABLISHMENT LABS HLDGS INC | COM | 682K | 15K | – |
| EVOLUS INC | COM | 12M | 1M | – |
| EXACT SCIENCES CORP | COM | 4M | 92K | – |
| FATE THERAPEUTICS INC | COM | 3M | 870K | – |
| GENEDX HOLDINGS CORP | COM CL A | 2M | 87K | – |
| GLOBUS MED INC | CL A | 6M | 86K | – |
| GSK PLC | SPONSORED ADR | 16M | 415K | – |
| HIMS & HERS HEALTH INC | COM CL A | 7M | 333K | – |
| HUMANA INC | COM | 17M | 44K | – |
| IDEAYA BIOSCIENCES INC | COM | 24M | 694K | – |
| IMMUNIC INC | COM | 8M | 7M | – |
| IMMUNOVANT INC | COM | 7M | 252K | – |
| INARI MED INC | COM | 20M | 408K | – |
| INHIBRX BIOSCIENCES INC | COM | 1M | 88K | – |
| INSMED INC | COM PAR $.01 | 7M | 102K | – |
| INSPIREMD INC | COM | 3M | 1M | – |
| INSULET CORP | COM | 4M | 19K | – |
| IO BIOTECH INC | COM | 225K | 193K | – |
| IOVANCE BIOTHERAPEUTICS INC | COM | 61M | 8M | – |
| IRADIMED CORP | COM | 4M | 102K | – |
| JANUX THERAPEUTICS INC | COM | 2M | 56K | – |
| JASPER THERAPEUTICS INC | COM NEW | 29M | 1M | – |
| JAZZ PHARMACEUTICALS PLC | SHS USD | 6M | 54K | – |
| KEROS THERAPEUTICS INC | COM | 10M | 222K | – |
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | 4M | 200K | – |
| KRYSTAL BIOTECH INC | COM | 23M | 126K | – |
| MEREO BIOPHARMA GROUP PLC | SPON ADS | 4M | 1M | – |
| MERUS N V | COM | 22M | 376K | – |
| MIMEDX GROUP INC | COM | 574K | 83K | – |
| NATERA INC | COM | 390K | 4K | – |
| NEUROPACE INC | COM | 18M | 2M | – |
| NOVOCURE LTD | ORD SHS | 2M | 109K | – |
| NURIX THERAPEUTICS INC | COM | 43M | 2M | – |
| NUVALENT INC | COM | 13M | 172K | – |
| OLEMA PHARMACEUTICALS INC | COM | 2M | 217K | – |
| ORGANOGENESIS HLDGS INC | COM | 32M | 12M | – |
| ORIC PHARMACEUTICALS INC | COM | 1M | 163K | – |
| ORTHOFIX MED INC | COM | 676K | 51K | – |
| ORTHOPEDIATRICS CORP | COM | 9M | 310K | – |
| PENUMBRA INC | COM | 22M | 123K | – |
| PHARVARIS N V | COM | 8M | 399K | – |
| PRAXIS PRECISION MEDICINES I | COM NEW | 22M | 533K | – |
| REVOLUTION MEDICINES INC | COM | 33M | 856K | – |
| RIGEL PHARMACEUTICALS INC | COM | 9M | 1M | – |
| SANOFI | SPONSORED ADR | 3M | 63K | – |
| SURMODICS INC | COM | 33M | 782K | – |
| SYNDAX PHARMACEUTICALS INC | COM | 17M | 827K | – |
| TANGO THERAPEUTICS INC | COM | 9M | 1M | – |
| TERNS PHARMACEUTICALS INC | COM | 34M | 5M | – |
| TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 10M | 586K | – |
| TG THERAPEUTICS INC | COM | 65M | 4M | – |
| THE BEAUTY HEALTH COMPANY | COM CL A | 3M | 2M | – |
| THERATECHNOLOGIES INC | COM NEW | 7M | 5M | – |
| TREACE MED CONCEPTS INC | COM | 16M | 2M | – |
| UNITED THERAPEUTICS CORP DEL | COM | 45M | 141K | – |
| VAXCYTE INC | COM | 14M | 185K | – |
| VERASTEM INC | COM NEW | 5M | 2M | – |
| VIRIDIAN THERAPEUTICS INC | COM | 4M | 340K | – |
| X4 PHARMACEUTICALS INC | COM | 2M | 4M | – |
| XERIS BIOPHARMA HOLDINGS INC | COM | 140K | 62K | – |
| Y-MABS THERAPEUTICS INC | COM | 8M | 648K | – |